Literature DB >> 29623599

A Rapidly Developing Diffuse Large B cell Lymphoma of the Stomach.

Atsushi Goto1, Jun Nishikawa2, Shunsuke Ito3, Eizaburou Hideura3, Ryo Ogawa3, Shinichi Hashimoto3, Takeshi Okamoto3, Isao Sakaida3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 29623599     DOI： 10.1007/s12029-018-0098-z

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  6 in total

Review 1.  Primary diffuse large B-cell lymphoma of the stomach.

Authors:  Andrés J M Ferreri; Carlos Montalbán
Journal:  Crit Rev Oncol Hematol       Date:  2007-03-06       Impact factor: 6.312

2.  Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.

Authors:  Mayumi Mori; Kiyoshi Kitamura; Michihiko Masuda; Tomomitsu Hotta; Tamotsu Miyazaki; Akira B Miura; Hideaki Mizoguchi; Akira Shibata; Hidehiko Saito; Tamotsu Matsuda; Toru Masaoka; Mine Harada; Yoshiyuki Niho; Fumimaro Takaku
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

3.  A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index.

Authors:  S Nakamura; K Akazawa; T Yao; M Tsuneyoshi
Journal:  Cancer       Date:  1995-10-15       Impact factor: 6.860

4.  Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends.

Authors:  Shotaro Nakamura; Takayuki Matsumoto; Mitsuo Iida; Takashi Yao; Masazumi Tsuneyoshi
Journal:  Cancer       Date:  2003-05-15       Impact factor: 6.860

Review 5.  Gastrointestinal lymphoma: recent advances in diagnosis and treatment.

Authors:  Shotaro Nakamura; Takayuki Matsumoto
Journal:  Digestion       Date:  2013-04-27       Impact factor: 3.216

6.  Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.

Authors:  C Denkert; S Loibl; B M Müller; H Eidtmann; W D Schmitt; W Eiermann; B Gerber; H Tesch; J Hilfrich; J Huober; T Fehm; J Barinoff; C Jackisch; J Prinzler; T Rüdiger; E Erbstösser; J U Blohmer; J Budczies; K M Mehta; G von Minckwitz
Journal:  Ann Oncol       Date:  2013-08-22       Impact factor: 32.976
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.